Literature DB >> 4018373

Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma.

R C Bast, R C Knapp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4018373     DOI： 10.1016/0028-2243(85)90130-3

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN： 0301-2115            Impact factor:   2.435


× No keyword cloud information.
  7 in total

1.  Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer.

Authors:  W Jäger; R Adam; L Wildt; N Lang
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

2.  HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases.

Authors:  Rafael Molina; Jose M Escudero; Jose M Augé; Xavier Filella; Laura Foj; Aureli Torné; Jose Lejarcegui; Jaume Pahisa
Journal:  Tumour Biol       Date:  2011-08-24

3.  Nidogen-2: a new serum biomarker for ovarian cancer.

Authors:  Cynthia Kuk; C Geeth Gunawardana; Antoninus Soosaipillai; Hiroshi Kobayashi; Lin Li; Yingye Zheng; Eleftherios P Diamandis
Journal:  Clin Biochem       Date:  2009-10-31       Impact factor: 3.281

4.  Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers.

Authors:  Cynthia Kuk; Vathany Kulasingam; C Geeth Gunawardana; Chris R Smith; Ihor Batruch; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2008-12-01       Impact factor: 5.911

5.  HE4 protein and SMRP: Potential novel biomarkers in ovarian cancer detection.

Authors:  Anna Fritz-Rdzanek; Wojciech Grzybowski; Jarosław Beta; Andrzej Durczyński; Artur Jakimiuk
Journal:  Oncol Lett       Date:  2012-06-13       Impact factor: 2.967

6.  Relationship between serum CA 125 levels, endometrial thickness and corpus luteum function in different stages of ovarian activity.

Authors:  G Ozakşit; N O Turhan; H Oral; N Doğu; O Gökmen
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

7.  Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.

Authors:  Bih-Rong Wei; Shelley B Hoover; Mark M Ross; Weidong Zhou; Francesco Meani; Jennifer B Edwards; Elizabeth I Spehalski; John I Risinger; W Gregory Alvord; Octavio A Quiñones; Claudio Belluco; Luca Martella; Elio Campagnutta; Antonella Ravaggi; Ren-Ming Dai; Paul K Goldsmith; Kevin D Woolard; Sergio Pecorelli; Lance A Liotta; Emanuel F Petricoin; R Mark Simpson
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.